Rimidi to Showcase New Chronic Kidney Disease Module at HLTH 2023, Complementing Suite of Chronic Disease Management Solutions
ATLANTA, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences, and achieve quality objectives for chronic disease management, today announced the launch of its new Chronic Kidney Disease (CKD) Module, designed to give providers better visibility on the status of their population of patients with CKD to improve disease management.
- Given that Rimidi already supports disease management and remote patient monitoring for diabetes and hypertension, two common risk factors for CKD, developing a full CKD Module was a natural platform progression.
- Similar to Rimidi's additional chronic disease modules , the CKD Module will combine clinically relevant data from the Electronic Health Record (EHR) with patient-generated data from connected devices and patient surveys into a streamlined, problem-oriented view that allows for better risk stratification and chronic disease management.
- The KFRE predicts the 5-year risk of end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD) stages 3-5.
- For more information about Rimidi's Chronic Kidney Disease Module, visit rimidi.com/chronic-kidney-disease or stop by booth #853 at HLTH 2023.